Aloha BioCBD+ Family,
It’s not often that you will hear us showcasing what our government is doing in a positive light, but here is one of those instances. This is a great move on behalf of the FDA and we could use your support, humanity could use your support! With your help, maybe the future will have the FDA more on our side than ever before.
The FDA is requesting public comments on the therapeutic value and abuse of cannabidiol (CBD), a non-psychoactive and medically beneficial cannabinoid derived from cannabis.
The deadline for submission is September 13th, 2017.
The UN’s World Health Organization (WHO) is seeking to determine how to designate CBD, alongside many other substances, within their international drug scheduling code. The FDA will consider these public comments in their formal response to WHO.
We have received hundreds of BioCBD+ testimonials and want to give you the opportunity to share your experience of CBD’s therapeutic properties for health and wellness.
Please click here to submit your comments with the option of remaining anonymous.
Thank you for voicing your comments to the FDA & WHO about CBD as a non-psychoactive, non-addictive, therapeutic substance and it’s lack of abuse potential.
Our all-natural CBD is voted #1 most effective.